PUBLIC COMPANY
saveCATALENT
USupdated 3mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Supernus, Indivior merger expected to result in ‘natural redundancies’Follow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 20h ago
- Lisata lays off 72% of staffers, sues Kuva after planned merger falls apartLisata is laying off 72% of its workforce, including its chief medical officer, as the solid tumor biotech tries to navigate a new future after a planned merger with cancer imaging company Kuva Lab…fiercebiotech · 1d ago
- Kyverna taps ElevateBio to secure commercial supply of autoimmune CAR-T therapyElevateBio will be the primary source of Kyverna’s autologous CAR-T cell therapy for anticipated U.S. and global launches in autoimmune indications.biospace · 6d ago
- Catalent to divest UK site; Rottendorf, Evonik announce manufacturing buildsPlus, news about RoslinCT, Novo Nordisk and more. 🇬🇧 Catalent to sell UK site to Codis: The CDMO is set to take Catalent’s oral solid dose factory in Nottingham, with ...endpoints · 26d ago
- Mammalian hair, roof leaks: Novo Nordisk's site in Indiana under FDA scrutiny once againNovo Nordisk’s troubled factory in Indiana that it got from Catalent continues to face contamination issues, with a re-inspection in April finding mammalian hair in finished drugs and water leaks t…endpoints · 2mo ago
- Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlookInvestors are still waiting to see whether Bristol Myers and Regeneron’s pipelines will deliver, while Biogen was lifted by better-than-expected results for newer drugs like Leqembi and Skyclarys.biopharma_dive · 3mo ago
comments(0)
5-min edit window · permanent after that